AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...
Aitia, the leader in the development and application of Causal AI and "Digital Twins" to discover and develop new drugs, announced a collaboration with...
Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, in collaboration with researchers at the Massachusetts Institute of Technology...
Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can...
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new...
